Dynamic tailoring of treatment durations improves efficiency of hepatitis C treatment with pegylated interferon and ribavirin-Reference-Cited by-同舟云学术

Dynamic tailoring of treatment durations improves efficiency of hepatitis C treatment with pegylated interferon and ribavirin

Published:2012-10-16 Issue:4 Volume:20 Page:e82-e89
ISSN:1352-0504
Container-title:Journal of Viral Hepatitis
language:en
Short-container-title:J Viral Hepat

Author:

Lindh M.¹,Arnholm B.²,Björkman P.³,Hellstrand K.¹,Lagging M.¹,Nilsson S.⁴,Wahlberg T.⁵,Wallmark E.³,Weiland O.⁶,Wejstål R.¹,Westin J.¹,Widell A.³,Norkrans G.¹

Affiliation:

1. Department of Infectious Diseases; University of Gothenburg; Gothenburg Sweden

2. Infectious Diseases Clinic; Borås Hospital; Borås Sweden

3. Department of Clinical Sciences; Malmö University Hospital; Malmö Sweden

4. Chalmers University of Technology; Gothenburg Sweden

5. Infectious Diseases Clinic; Central Hospital; Skövde Sweden

6. Division of Infectious Diseases; Karolinska Institute, Karolinska University Hospital Huddinge; Stockholm Sweden

Funder

Västra Götalandsregionen

ALF-LUA

Roche Pharma

Publisher

Wiley

Subject

Virology,Infectious Diseases,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jvh.12014/fullpdf

Reference17 articles.

1. Diagnosis, management, and treatment of hepatitis C: an update;Ghany;Hepatology,2009

2. Early identification of HCV genotype 1 patients responding to 24 weeks peginterferon alpha-2a (40 kd)/ribavirin therapy;Jensen;Hepatology,2006

3. Efficacy of 24 weeks treatment with peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C infected with genotype 1 and low pretreatment viremia;Zeuzem;J Hepatol,2006

4. Extended treatment duration for hepatitis C virus type 1: comparing 48 versus 72 weeks of peginterferon-alfa-2a plus ribavirin;Berg;Gastroenterology,2006

5. Treatment extension to 72 weeks of peginterferon and ribavirin in hepatitis c genotype 1-infected slow responders;Pearlman;Hepatology,2007

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Pharmacokinetic–Viral Kinetic Model Describes the Effect of Alisporivir as Monotherapy or in Combination With Peg-IFN on Hepatitis C Virologic Response;Clinical Pharmacology & Therapeutics;2014-08-28